Speakers

Dr. Martin Alexander Gershon, MD, JD, MPH is the CEO Managing Partner and Chief Strategy Officer of the Endeavor Group and its three subsidiaries, Endeavor Venture Capital, Endeavor Communications, and Endeavor Strategic Growth Advisors, and serves as the Senior Executive Investor-in-Residence and Lead Mentor-in-Residence at Techstars, Advisor to the White House Moonshot CancerX Accelerator, and Senior Advisor to Fortune 500 Healthcare, Big Tech and Financal Services Companies.

Dr. Gershon is recognized as one of the leading healthcare investors, growth strategists, and futurists. He is a Linkedin  “Top Voice” in Venture Capital and Entrepreneurship, honored by Standard and Poor’s as a designated Top 100 Healthcare Industry Leader, and featured on CNBC and in numerous conferences and publications as a changemaker who drives prescient, future facing investment decisions, always “skating to where the puck is going, not where it is.”

Over the past 25 years Dr. Gershon has served as a Senior Strategic Advisor, dedicated to developing growth strategies and commercializing innovative technologies for prominent Fortune 500 Companies, world class accelerators, and global leaders including McKinsey, Goldman Sachs, Bain Capital, BlackRock, American Express, Tiger Global, GlaxoSmithKline, Bristol-Myers Squibb, Pfizer, Novartis, Fidelity Investments, Pictet Asset Management, Senator Hillary Rodham Clinton, Senator John Kerry, Ambassador Richard Holbrooke, the Federal Reserve Board of Governors, the Bill and Melinda Gates Foundation, and the Rockefeller Foundation.
 
Since 1999 Dr. Gershon has led Endeavor Venture Funds to over 100 investments and 24 exits, founded 6 startups, and built a thriving ecosystem of partnerships and collaborations in Biopharma, Biotech, Healthtech, Ivy League Academic Medical Centers, Big Tech, Banking and Venture Capital, including Microsoft, Google, Intersystems, Merck, Sanofi, HSBC, Mount Sinai Health Systems, Mass General Brigham, Memorial Sloan-Kettering Cancer Center, SUNY Downstate Medical Center, the National Institutes of Health, Johns Hopkins, Columbia, NYU, McGill, and Harvard, establishing a deep network of C-Suite thought leaders who act as an Advisory Council for Endeavor’s Fortune 500 clients and hyper-growth emerging startups who are looking for help in designing and implementing forward looking go-to-market and growth strategies now for the digital future ahead.

Endeavor Communications has built a robust social media platform that has showcased over 60 remarkable emerging Seed and Series A companies in partnership with world class accelerators like Microsoft Pegasus and Foundation Hub, TechStars, PlugNPlay, MassChallenge, Merck Digital Sciences Studio, and Matter Health. The Endeavor communications platform is driven by Dr. Gershon who serves as a contributing writer for Fast Company on healthcare venture capital and entrepreneurship and is the carismatic Host of the popular Endeavor BetterHealth Webinar Series with 2M views, Editor-in-Chief for Partnering for BetterHealth Newsletter with 27k+ subscribers, and Host and Anchor of the HLTH Masterclasses on AI and Healthcare serving the HLTH community of 50k+ biopharma senior executives.
 
Dr. Gershon also has a prominent academic, teaching and mentoring career. He is a Harvard, McGill and Columbia trained neuroscientist, oncologist and immunologist, former FDA attorney, an award winning Google Scholar in Entrepreneurship, and Juilliard trained musician. He has served as the Aspen Institute Business of Health Chair and Senior Fellow, Memorial Sloan-Kettering Cancer Center Mayday Fellow, Executive-in-Residence Matter Health, and has been a Senior Lecturer of Healthcare Economics and Entrepreneurship at Johns Hopkins in the Advanced Biotechnology Program, Guest Lecturer of Healthcare AI and Venture Investing at the Johns Hopkins School of Business, Professor of Healthcare Policy and Finance at Columbia School of Public Health, Professor of Healthcare Innovation and Entrepreneurship and Chief Innovation and Investment Officer at McGill, Guest Lecturer of Drug Development and Drug Discovery at Harvard and MIT in the Health, Science and Technology Program, and Guest Lecturer of Healthcare AI and Digital Innovation at the NYU Entrepreneurial Institute and the School for Professional Studies.